# Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

> **NCT00127959** · PHASE4 · COMPLETED · sponsor: **International Antiviral Therapy Evaluation Center** · enrollment: 24 (—)

## Conditions studied

- HIV Infections
- Hepatitis B

## Interventions

- **DRUG:** tenofovir
- **DRUG:** emtricitabine
- **DRUG:** zidovudine
- **DRUG:** efavirenz

## Key facts

- **NCT ID:** NCT00127959
- **Lead sponsor:** International Antiviral Therapy Evaluation Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2007-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127959, "Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00127959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*